WallStreetZen

NASDAQ: VXRT
Vaxart Inc Stock

$6.93-0.45 (-6.10%)
Updated May 6, 2021
VXRT Price
$6.93
Fair Value Price
N/A
Market Cap
$758.62M
52 Week Low
$2.23
52 Week High
$24.90
P/E
-19.25x
P/B
6.15x
P/S
423.22x
PEG
N/A
Dividend Yield
0%
Revenue
$4.05M
Earnings
-$46.93M
Gross Margin
100%
Operating Margin
-790.46%
Profit Margin
-796.3%
Debt to Equity
0.24
Operating Cash Flow
-$37M
Beta
-0.24
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

VXRT Overview

Zen Score

High
Medium
Low
25
Industry average

Reasons for this score

VXRT is poor value based on its book value relative to its share price (6.15x), compared to the US market average (0.6x)
Valuation
VXRT is poor value based on its book value relative to its share price (6.15x), compared to the US Biotechnology industry average (6.01x)
Valuation
VXRT's cash and short-term investments ($126.87M) can cover VXRT's cash burn for the next year ($24.97M), even accounting for increasing cash burn (113.84%)
Financials

1 of 7

VXRT News

Valuation

VXRT fair value

Fair Value of VXRT stock based on Discounted Cash Flow (DCF)
Price
$6.93
Fair Value
$8.84
Undervalued by
21.61%

VXRT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-19.25x
Industry
66.59x
Market
27.98x

VXRT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
6.15x
Industry
6.01x
Market
0.6x
VXRT is poor value based on its book value relative to its share price (6.15x), compared to the US market average (0.6x)
Valuation
VXRT is poor value based on its book value relative to its share price (6.15x), compared to the US Biotechnology industry average (6.01x)
Valuation

VXRT's financial health

Profit margin

Revenue
$506.0k
Net Income
-$16.0M
Profit Margin
-3,163.4%
VXRT's cash and short-term investments ($126.87M) can cover VXRT's cash burn for the next year ($24.97M), even accounting for increasing cash burn (113.84%)
Financials
VXRT's profit margin has decreased (-607.2%) in the last year from (-189.1%) to (-796.3%)
Financials

Assets to liabilities

Assets
$205.9M
Liabilities
$29.6M
Debt to equity
0.04
VXRT's short-term assets ($128.53M) exceed its short-term liabilities ($11.76M)
Financials
VXRT's short-term assets ($128.53M) exceed its long-term liabilities ($17.42M)
Financials
VXRT's debt has increased relative to shareholder equity (0.24), over the past 5 years ago (0.12)
Financials
VXRT's debt to equity ratio (0.24) is considered acceptable
Financials

Cash flow

Operating
-$16.6M
Investing
-$20.6M
Financing
$67.6M
VXRT's cash and short-term investments ($126.87M) can cover VXRT's cash burn ($24.97M) for at least 1 year
Financials

Vaxart Stock FAQ

What is Vaxart's quote symbol?

(NASDAQ: VXRT) Vaxart trades on the NASDAQ under the ticker symbol VXRT. Vaxart stock quotes can also be displayed as NASDAQ: VXRT.

What is the 52 week high and low for Vaxart (NASDAQ: VXRT)?

(NASDAQ: VXRT) Vaxart's 52-week high was $24.90, and its 52-week low was $2.23. It is currently -72.17% from its 52-week high and 210.76% from its 52-week low.

How much is Vaxart stock worth today?

(NASDAQ: VXRT) Vaxart currently has 109,468,945 outstanding shares. With Vaxart stock trading at $6.93 per share, the total value of Vaxart stock (market capitalization) is $758.62M.

Vaxart stock was originally listed at a price of $224.82 in Dec 31, 1997. If you had invested in Vaxart stock at $224.82, your return over the last 23 years would have been -96.92%, for an annualized return of -14.04%.

How much is Vaxart's stock price per share?

(NASDAQ: VXRT) Vaxart stock price per share is $6.93 today (as of May 6, 2021).

What is Vaxart's Market Cap?

(NASDAQ: VXRT) Vaxart's market cap is $758.62M, as of May 9, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Vaxart's market cap is calculated by multiplying VXRT's current stock price of $6.93 by VXRT's total outstanding shares of 109,468,945.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.